Consumer red-light and near-infrared panels

1. Introduction

Version followed: the method as described in US FDA 510(k) clearance documents for over-the-counter LED panels and infrared lamps, FDA's general wellness policy page, the UK Advertising Standards Authority (ASA) and MHRA position on LED-mask claims as reported in the trade press, an Australian TGA-linked recall, an FTC enforcement action, and one seller's published safety page. The psychotherapist's work alongside it (section 4) is built from these sources plus established psychotherapy practice, marked [synthesis] where it is not drawn from a cited source.

The psychotherapist works alongside this method and does not use, sell, prescribe or recommend red-light or near-infrared devices. The guide equips you to talk about them knowledgeably and safely when clients use them.

What is sold. Consumer red-light and near-infrared devices include full-body and half-body LED panels, face masks, handheld wands, wraps and pads, and infrared heat lamps, sold for home use and offered in gyms, spas, salons and "wellness" studios. The industry term is photobiomodulation (PBM), also called low-level light or laser therapy (LLLT). [source: FDA K180320; FDA K080465; Mito Red Light safety page; FTC 2020]

Core idea of change, as sellers state it. Sellers describe a "photochemical pathway" in which light absorbed by a mitochondrial enzyme, cytochrome c oxidase, drives cellular signalling. They contrast this with ultraviolet and with drugs to argue for a low-risk profile. Marketing attaches this mechanism to a wide range of general "healing", recovery, skin, pain and wellbeing claims. [source: Mito Red Light safety page] These are attributed claims. Some products hold FDA clearance only for narrow cosmetic or symptomatic indications (section 2). Evidence status in one line: research is described as limited, with many small and some manufacturer-funded studies, and results are typically more modest than in-office treatment. [source: Boulder Medical Center, a clinic web page; uncertain: secondary, unverified] No red-light product is presented here as a treatment for cancer or any other physical disease.

Not the same as bright light therapy. Bright light therapy for seasonal affective disorder (SAD), using a "SAD lamp" or light box that mimics daylight, is a different intervention with different devices and its own cautions. It is covered in Domain IX. [source: NHS SAD treatment page]

2. Framework

2a. The method as its sellers and regulators describe it

Product types. LED panels and masks emitting red and/or near-infrared light; some masks also emit blue light, sold for acne. Infrared heat lamps are a separate category. [source: FDA K180320; FDA K080465; TGA recall]
What a client experiences. Typically the client sits, stands or lies in front of a panel, or wears a mask or wrap, often at home, sometimes in a gym or salon booth. Sellers describe it as painless, with possible warmth and mild, temporary redness. Some devices come with goggles, and sellers advise eye protection, keeping the eyes closed and not looking into the LEDs. [source: FDA K180320; Boulder Medical Center; Mito Red Light] This guide gives no wavelengths, intensities, distances, programmes or session lengths.
Who supplies or delivers it. Consumers self-administer at home. Gyms, spas, beauty salons and wellness studios offer sessions. Clinicians such as dermatologists and physiotherapists use clinical photobiomodulation in some settings. [synthesis, from product sources] No single professional body or licence covers consumer use. [uncertain: not verified]
Seller-listed cautions. One seller lists these as reasons to avoid use or to get medical clearance first: active cancer or suspicious lesions in the treatment area; photosensitive epilepsy, with flicker as the concern; high-intensity exposure of the eyes; pregnancy, for abdominal or low-back use; photosensitising medicines (examples given: some antibiotics, acne drugs, diuretics); lupus and other photosensitive conditions; active eye disease; thyroid disease, for neck use; fever or acute infection; and reduced sensation or neuropathy, which raises the risk of overuse. It also mentions recent burns, fresh tattoos, melasma, children and adolescents, and heat sensitivity in darker skin. [source: Mito Red Light safety page] These are a seller's statements, not regulatory contraindications.

2b. Regulatory status, one line per jurisdiction

United States (FDA). Many LED panels and masks are 510(k)-cleared Class II devices for specific over-the-counter cosmetic indications. One panel, for example, is cleared under 21 CFR 878.4810 for wrinkles and mild to moderate inflammatory acne. [source: FDA K180320] Infrared heat lamps are Class II under 21 CFR 890.5500 for indications such as temporary relief of minor muscle and joint pain and a temporary increase in local circulation. [source: FDA K080465] Clearance means FDA accepted the device as substantially equivalent to an existing device for that indication. It is not "FDA approval" and does not cover other claims. Some products are marketed under FDA's general wellness policy for low-risk products that promote a healthy lifestyle (guidance revised January 2026). [source: FDA general wellness page] One seller states that its products are not FDA-cleared to diagnose, treat, cure or prevent any disease. [source: Mito Red Light]
United States (FTC). In 2020 the FTC settled with Physicians Technology LLC and Willow Labs LLC over an infrared light-therapy device. The FTC said the companies falsely claimed the device treated chronic severe pain and inflammation, was "clinically proven" and was FDA-approved; it also cited disguised "native" ads and a misleading refund guarantee. The order included a $22 million judgment, partly suspended. [source: FTC 2020]
United Kingdom (MHRA, ASA). Medical claims such as treating acne or rosacea are allowed only for products registered with the MHRA as medical devices. In 2025 the ASA ruled against ads from four LED-mask brands. It held that even "acne-related redness" and customer testimonials count as medical claims. [source: Cosmetics Business 2025]
Australia (TGA). A red/blue light acne mask listed on the ARTG was recalled in 2019 after visual adverse events. The recall named retinal risk for people with certain hereditary eye conditions and for people taking medicines that increase the eye's sensitivity to light. [source: Product Safety Australia/TGA recall]
European Union and Canada. [uncertain: not verified]
Evidence status. Limited. A systematic review of home-use photobiomodulation devices found eleven studies with mostly positive results across pain, wound healing and other uses, but concluded that more randomised controlled trials are needed before efficacy can be judged. [source: Gavish & Houreld 2019] The French public health information service says red or near-infrared LED masks may help with fine wrinkles, but the studies are low grade, protocols vary too much to set usage guidance, effects take weeks to months and their durability is unknown; no long-term safety studies exist. [source: Santé.fr 2026]

2c. The psychotherapist's framework alongside it [synthesis]

This work has no session count of its own. It is woven into ongoing therapy in four overlapping phases:

Inquire and record. Covered at intake and at review. Move on once use is documented.
Understand meaning. Explore what the device means to the client: hopes, explanatory model, cost, time. Move on once you understand the role it plays.
Support decisions and coordinate care. Support values-based choices and, with consent, liaise with the GP, pharmacist, dermatologist or optometrist. Move on once safety questions have gone to the right professional.
Monitor risk and review. Watch for delayed care, physical harm, compulsive or costly use, and appearance-focused distress. Return to phase 1 whenever use changes.

3. Guiding principles

[synthesis unless tagged]

Never perform, sell, prescribe or recommend. Do not suggest devices, brands, settings or schedules, and do not run a panel in your room.
Curiosity without judgement. Clients disclose more when the topic is normalised. Ask routinely, not only when you suspect a problem.
Attribute, don't adjudicate. Describe claims as the seller's ("the company says…"). Neither endorse nor ridicule them.
Distinguish cleared from claimed. FDA clearance covers a specific indication only. "Cleared" is not "approved", and "wellness" is not "treatment". [source: FDA K180320; FTC 2020]
Medical questions go to medical professionals. Questions about medicines, eyes, skin lesions, pregnancy, epilepsy and pain go to the prescriber, pharmacist, optometrist or GP. Never advise starting, stopping or changing a medicine.
Red light is not SAD light therapy. Do not let a client substitute a red-light panel for assessed mood treatment. Light therapy for mood is covered in Domain IX.
Autonomy plus safety. Adults may choose wellness products. Your role is informed choice, not compliance. Act on risk, not preference.
No conflicts of interest. Hold no affiliate links, discounts or business ties to device sellers, and disclose any that exist.
Document. Record what the client uses, any medical liaison, and risk decisions.

4. Intervention inventory

Everything below is the psychotherapist's own work. Wording and step sequences are [synthesis] unless a source is tagged.

4.1 Routine, non-judgemental inquiry and recording

Purpose. Find out what light devices, salon or gym sessions, and related products the client uses. Use it at intake, at reviews, and when new physical symptoms, sleep or mood changes, appearance concerns or financial strain come up.
Steps.
1. Normalise the question by asking it among other self-care and complementary practices.
2. Ask what device or service they use, for what purpose, who suggested it, roughly what it costs, and whether their doctor knows. Do not ask for settings and do not comment on them.
3. Ask about medicines and health conditions only in order to know whether a medical conversation is needed (see 4.5). Do not assess interactions yourself.
4. Record the product category, the purpose, any claims the client reports, any medical liaison, and the client's own words about benefit.
Example language (illustrative). "Lots of people use things at home for their health or skin, like supplements, apps, light panels or masks. Is any of that part of your routine?" / "What made you start with the red-light panel, and what do you hope it does for you?"
Watch for. Shame, defensiveness, or expecting you to disapprove. Use described as treating a diagnosed condition or replacing treatment. A device bought on the strength of "FDA approved" or "clinically proven" claims. [source: FTC 2020] It is working when the client volunteers updates on use without prompting.

4.2 Exploring meaning, hopes, expectations and the explanatory model

Purpose. Understand what the device does psychologically: a sense of control, hope, optimisation identity, belonging to a fitness or "biohacking" community, distrust of medicine, or managing appearance anxiety.
Steps.
1. Elicit the client's own model of how it works. Reflect it back, attributed to them or the seller ("so the idea is the light works on your cells' energy").
2. Explore the hopes and fears behind the purchase, and what would count as success.
3. Explore cost in money, time and attention, and what it competes with.
4. Link the themes to the formulation: control after illness, perfectionism, body image, or health worry.
Example language (illustrative). "If it worked exactly as you hope, what would be different?" / "What does using it each day give you, apart from what it does to your skin or muscles?" / "When you miss a session, what goes through your mind?"
Watch for. Rigid or compulsive routines, distress when a session is missed, escalating purchases, magical expectations (curing a serious illness), or a narrative that medicine has failed and this is the only hope. It is working when the client can name their needs separately from the product.

4.3 Psychoeducation on claims and regulatory language

Purpose. Help the client read marketing critically without your endorsing or condemning any product. Use it when the client cites "FDA approved", "clinically proven", or medical-sounding claims.
Steps.
1. Explain the difference between "cleared" (a 510(k) for a specific indication) and "approved", and that clearance does not extend to other claims. [source: FDA K180320; FDA K080465]
2. Explain that "wellness" products are a separate low-risk category, not a treatment claim. [source: FDA general wellness page]
3. Note that regulators have acted against unsupported claims: the FTC's Willow Curve case, and the ASA's 2025 rulings that acne or rosacea claims need MHRA registration and that testimonials count as claims. [source: FTC 2020; Cosmetics Business 2025]
4. Invite the client to check what their specific product is cleared for, or to ask their doctor or pharmacist. Do not research or vet products for them.
Example language (illustrative). "'FDA-cleared' usually means cleared for one specific use, such as wrinkles. It doesn't mean it's been shown to help everything on the website. Your GP or pharmacist could tell you more about what the label means for you."
Watch for. Feeling criticised (repair: "I'm not saying stop. I want you to have the full picture."), or swinging into catastrophic fear. It is working when the client separates the labelled use from the marketing claims.

4.4 Supporting informed, values-based decisions without coercion

Purpose. Help clients decide about starting, continuing, spending more on, or stopping use, according to their values, without your steering towards or away from the device. Use it when the client is ambivalent, spending heavily, or under pressure from a seller, partner or group.
Steps.
1. Clarify the decision and who else is involved.
2. Elicit values: health, money, time, appearance, autonomy, relationships.
3. Lay out what the client knows and doesn't know, and which questions belong to a doctor or optometrist.
4. Use simple pros-and-cons or motivational-interviewing reflections. No published decision aid specific to these devices has been verified [uncertain: not verified].
5. Respect the decision and agree on review points.
Example language (illustrative). "It sounds like part of you is excited about the bigger panel and part of you is worried about the cost. What matters most to you here?"
Watch for. Asking you to decide ("Would you buy it?"): decline and redirect to the client's values. Signs of external pressure or sunk-cost thinking. It is working when the client states the decision in their own words, consistent with their values.

4.5 Coordinating with the doctor, pharmacist, dermatologist or optometrist

Purpose. Route medical-safety questions to the right professional, with consent. This applies when the client:
- takes medicines that may increase light sensitivity;
- has an eye condition, epilepsy, pregnancy, lupus or another photosensitive condition, a thyroid condition, reduced sensation, or a changing skin lesion;
- uses the device for a medical symptom. [source: TGA recall; Mito Red Light; NHS SAD page]
Steps.
1. Explain why a medical check helps, without diagnosing.
2. Obtain written consent covering what to share and with whom.
3. Encourage the client to raise it directly, or send a brief factual note: product category, purpose, and the client's question. Do not include your opinion on efficacy.
4. Never advise starting, stopping or changing any medicine. Direct the client to the prescriber or pharmacist.
5. Record the outcome.
Example language (illustrative). "Some medicines make the skin and eyes more sensitive to light. That's a question for your pharmacist, not me. Would you be willing to ask them about your tablets and this panel?"
Watch for. Reluctance to tell the doctor, which may signal fear of judgement or replacement of care (explore it). Eye or skin symptoms reported in session (see 4.7). It is working when the medical question has been asked and answered by the right person.

4.6 Distinguishing red-light panels from bright light therapy for mood

Purpose. Prevent a red-light panel being used as self-treatment for depression or SAD instead of assessed care, and make sure mood-related light use is medically overseen. Use it when the client says the panel is "for my mood", "for winter", or "for my energy".
Steps.
1. Clarify the device. A SAD lamp or light box mimics daylight and is a different product from red or near-infrared panels. [source: NHS SAD page]
2. Assess mood with your usual measures and risk assessment.
3. Tell the client that the NHS advises speaking to a GP before using light therapy for SAD, that it may not suit people with some eye conditions or taking light-sensitising medicines, and that NHS treatment options for SAD include talking therapies and antidepressants. [source: NHS SAD page]
4. For clients with a bipolar history, raise the question of light and mood with their psychiatrist or GP before any light-based mood strategy. [synthesis] The NHS SAD page does not address bipolar disorder, so details of risk are [uncertain: not verified]. See Domain IX.
Example language (illustrative). "The red panel and a SAD lamp are quite different things. If winter is pulling your mood down, let's look at that properly, and it's worth a word with your GP before using any light for mood."
Watch for. Untreated depression being managed only with a device. Elevated mood, reduced sleep or agitation in clients with a bipolar history: escalate to the prescriber. It is working when mood is being assessed and treated through appropriate channels.

4.7 Recognising and responding to risk

Purpose. Spot physical, psychological, financial and safeguarding risks linked to use. Act proportionately and refer.
Steps and risk areas.
- Delayed or replaced medical care. For example, using a panel on a changing mole, persistent pain, a wound or a diagnosed disease instead of seeing a clinician. Ask directly. Encourage prompt medical review, and with consent, liaise (4.5). One seller lists active cancer or suspicious lesions in the treatment area as a reason to avoid use. [source: Mito Red Light]
- Eye symptoms. Visual disturbance, pain or light sensitivity after use. Advise prompt review by an optometrist, eye casualty or GP. Regulators recalled one acne mask after visual adverse events, citing retinal risk for people with certain hereditary eye conditions or taking medicines that make the eye more light-sensitive. [source: TGA recall] A published case report describes photochemical retinopathy with distorted vision in a woman a month after exposure to blue light from an LED face mask; the authors urge keeping the eyes covered during mask use. [source: Kim et al. 2020] The French public health information service advises against blue-light masks for home use, while noting no reported accidents with red or near-infrared LEDs. [source: Santé.fr 2026]
- Skin burns or heat injury. Redness that persists, blistering, or pain. Advise medical review. Reduced sensation (neuropathy) is listed by one seller as raising overuse risk. [source: Mito Red Light] Published burn case reports for consumer LED panels: [uncertain: not verified].
- Seizures. Photosensitive epilepsy with flickering or pulsed devices: the seller lists it as a reason to avoid use. [source: Mito Red Light] Direct to the neurologist or GP.
- Pregnancy and children. One seller advises medical clearance in pregnancy for abdominal or low-back use and lists children and adolescents as a caution. [source: Mito Red Light] Encourage the client to consult their midwife, GP or paediatrician. Where a child's medical care is being withheld or replaced, follow safeguarding procedures (4.10).
- Financial exploitation and sales pressure. Expensive panels, subscription sessions, affiliate or multi-level marketing schemes, misleading guarantees. The FTC case cited a refund guarantee that left buyers without refunds. [source: FTC 2020] Explore debt, secrecy and pressure from recruiters or an online group.
- Compulsive or escalating use. Increasing time, devices or spending, or distress when unable to use it. Formulate it as you would other compulsive behaviour. [synthesis]
Example language (illustrative). "You mentioned your eyes felt strange after the mask. That's something I'd like you to get checked today or tomorrow by an optometrist or your GP. Can we work out how?"
Watch for. Minimisation ("it's only light"). Signs of coercion by a partner or group. It is working when risks are named, medical review is arranged, and the client feels respected rather than told off.

4.8 Health anxiety, somatic symptoms and optimisation preoccupation

Purpose. Address device use that functions as safety behaviour, reassurance-seeking or checking in health anxiety, in somatic symptom presentations, or in perfectionistic "optimisation". Cross-refer Domain II.
Steps.
1. Map the cycle: trigger, then worry, then device use, then short-term relief, then return of the worry.
2. Use established CBT approaches for health anxiety or somatic symptoms from Domain II: formulation, attention-shifting, behavioural experiments, and gradually reducing safety behaviours by the client's choice. Never instruct changes to medical treatment.
3. Hold the device as the client's choice. The target is the anxiety cycle, not the panel.
Example language (illustrative). "When the worry about inflammation comes up, the panel seems to settle it for a while. What happens to the worry an hour later?"
Watch for. Substitution of one safety behaviour for another. Escalating body scanning. It is working when anxiety falls without needing more device use.

4.9 Appearance concerns and body image

Purpose. LED masks and panels are often marketed for skin and ageing. Assess for body-image distress, body dysmorphic concerns or eating-disorder features when use is appearance-driven. [synthesis]
Steps. Screen with your usual body-image and eating-disorder questions. Explore time spent on appearance routines and mirror checking. Refer to or apply specialist protocols (cross-ref Domain II and the eating-disorder entries) where indicated.
Example language (illustrative). "How much of your day goes into thinking about your skin? How do you feel when you look in the mirror after using the mask?"
Watch for. Escalation to more invasive cosmetic procedures, avoidance of social contact, and restriction of food alongside "wellness" routines. It is working when appearance becomes one value among others.

4.10 Reporting routes

Purpose. Know where clients, or you with consent, can report injuries, misleading claims or exploitation.
Routes.
- Device injuries or adverse events. Report to the national device regulator: FDA in the US, MHRA in the UK, TGA in Australia. The recall notice directs questions to the TGA. [source: TGA recall] The specific reporting schemes (FDA MedWatch, MHRA Yellow Card): [uncertain: not verified].
- Misleading advertising. The FTC in the US [source: FTC 2020] and the ASA in the UK. The ASA acts on medical claims, including testimonials. [source: Cosmetics Business 2025] Australia's consumer regulator: [uncertain: not verified].
- Professional misconduct. Report a licensed clinician selling or making disease claims for devices to the relevant professional board. [synthesis]
- Safeguarding. For a child or adult at risk who is being deprived of medical care or exposed to harm, follow local safeguarding procedures and your duty-to-report law. [synthesis]
Steps. Explain the options, support the client to report, and document. Report yourself only with consent or where a safeguarding or legal duty overrides confidentiality.
Example language (illustrative). "If the ad said it would cure your pain and it didn't, you can complain to the advertising regulator. Would you like to look at how together?"
Watch for. Fear of retaliation, or embarrassment at having been misled. Normalise both. It is working when the client feels the choice to report is theirs.

4.11 Managing your own role: boundaries, conflicts of interest and documentation

Purpose. Keep the therapeutic frame clean. [synthesis] Specific ethics-code provisions on conflicts of interest: [uncertain: not verified].
Steps. Do not use, demonstrate, sell or rent devices, and do not hold affiliate codes. Do not offer red-light sessions as an add-on to therapy. Decline requests to recommend a brand. Record complementary use, liaison and risk decisions in the notes. If you personally use such devices, keep that out of the work unless disclosure clearly serves the client.
Example language (illustrative). "I can't recommend a particular device. That's outside my role. What I can do is help you think the decision through and work out who to ask about the medical side."
Watch for. Pressure to collude or to take sides in a family dispute about spending. Your own enthusiasm or scepticism leaking into the work. It is working when the client experiences you as neutral and safety-focused.

5. Handling problems

[synthesis throughout, except where a source is tagged]

Client feels judged and becomes guarded. Repair explicitly: "I ask everyone about this. I'm not against it." Return to curiosity about meaning (4.2).
Client insists the panel treats a serious condition and is delaying care. Stay with the person, not the product. Explore fears about medical care, such as past bad experiences or fear of the diagnosis. Ask permission to share the concern that delay could matter. Offer to help them prepare for a GP appointment and, with consent, liaise. Document. If capacity or safeguarding is in question, follow local procedures.
Client asks you to recommend a device or settings. Decline warmly (4.11). Redirect to their values and to their GP, pharmacist or dermatologist.
Client reports eye or skin symptoms. Treat it as a prompt for medical review the same or next day, depending on severity. Do not interpret the symptoms yourself. [source: TGA recall; Kim et al. 2020]
Client is on light-sensitising medicines and won't ask the pharmacist. Explore the barrier. Offer to rehearse the conversation, or, with consent, contact the pharmacist. Never suggest changing the medication. [source: TGA recall; Mito Red Light]
Stuck in ambivalence about an expensive purchase or subscription. Use decisional-balance work and time-limited deferral ("If you still want it in a month, what would you need to know?"). Explore pressure from sellers or online communities.
Multi-level marketing or group pressure. Explore social costs and recruitment pressure. Support boundary-setting scripts. Watch for high-control dynamics such as isolation, shaming of doubters and escalating payments.
Mood disorder being self-treated with a red-light panel. Assess mood and risk, explain the difference from SAD light therapy, and refer to the GP or psychiatrist. [source: NHS SAD page] Bipolar history: escalate to the prescriber. [uncertain: not verified]
Health-anxiety cycle maintained by device use. Formulate, then use the Domain II CBT approaches (4.8). Reduce safety behaviours by the client's choice, never as a condition of therapy.
Rupture after you share concerns. Acknowledge the impact, restate respect for their autonomy, and check what they need from you.
Family conflict about use, such as a partner furious about spending or a parent using a device on a child. Hold a systemic view. For a child, consider assent and consent, medical oversight and safeguarding duties.
Client was misled by advertising and feels foolish. Normalise the experience: regulators have acted against exactly these claims. [source: FTC 2020; Cosmetics Business 2025] Offer the reporting routes (4.10).
Situations the sources don't address. Examples: a client who wants to use a panel in your waiting room, or a colleague selling devices to clients. Decline, and raise the issue through supervision and the professional board as appropriate.

Sources

← Previous · XII-084Consumer PEMF devices (BEMER)Next · XII-087 →Scalar and quantum pendants